CClinicalTrials.gg
CompletedNCT01541917WebSMARTUpdated Mar 9, 2017Results posted

Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis

A Phase 3 interventional study of Web-based coping skills training and Online disease education in Juvenile Idiopathic Arthritis, sponsored by Children's Mercy Hospital Kansas City. Completed at 10 sites in United States. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2017-03-09.

Sponsored by Children's Mercy Hospital Kansas City · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
305
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

The purpose of this multi-site randomized clinical trial is to determine if an online coping skills training program will produce superior improvements in pain and health-related quality of life outcomes for adolescents with JIA relative to outcomes attained with reviewing online educational information about JIA.

Read the detailed description

There is a critical gap in the contemporary treatment of Juvenile Idiopathic Arthritis (JIA) wherein a majority of adolescent patients still experience ongoing pain and reduced health-related quality of life even with advances in medical management of the disease. Despite the pervasiveness of this problem, most adolescents receive no training in the strategies that can help empower them to reduce pain and disability. The Internet offers a unique opportunity to reach adolescents with JIA and provide the training in pain self-management strategies that otherwise may not occur due to treatment access and resource obstacles. The objective of this research study is to conduct a definitive test of an investigator-developed online coping skills training program for English- and Spanish-speaking adolescents with JIA. Based on data from the investigators' preliminary work, the central hypothesis is that use of an online coping skills training program will produce superior improvements in pain and health-related quality of life outcomes for adolescents with JIA relative to outcomes attained with reviewing extant online educational information about JIA and receiving additional attention to coping efforts (control condition). Specific aims for the proposed work include (a) determining the extent to which an online coping skills training program for adolescents with JIA produces improvements in key health outcomes that currently do not optimally respond to only contemporary medical management (pain and health-related quality of life); and (b) determining predictors of change in pain and health-related quality of life indices in adolescents with JIA and establishing the extent to which online coping skills training influences health outcomes via these predictors. An exploratory aim is to determine the acceptability and preliminary efficacy of online coping skills training within a subgroup of Hispanic adolescents with JIA. These aims will be achieved through the approach of using a multi-center randomized controlled trial in which a sample of 360 consenting English- and Spanish-speaking adolescents aged 12-18 years with JIA will be enrolled and randomized into one of two groups: (a) an experimental group consisting of a 12-week interactive online multi-component treatment protocol including targeted disease education, training in empirically supported cognitive-behavioral coping skills, and social support augmented by monthly telephone contact with a nurse; or (b) a control group consisting of 12 weeks of guided access to extant online resources for disease education and additional attention to own best efforts at managing JIA via monthly telephone contact with a nurse. Outcome data will be collected from both groups prior to treatment, immediately following the intervention, and at 6- and 12-month follow-up assessments. Successful completion of this project is expected to establish to what extent and how an innovative online self-management program produces change in clinically relevant health outcomes in both English- and Spanish-speaking adolescents with JIA. The proposed study therefore can be expected to have a significant positive impact in the healthcare of teens with JIA and in identifying treatment targets for other youth self-management interventions.

02

Conditions studied

  • Juvenile Idiopathic Arthritis
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.

This study's enrollment of 305 is above the median of 90 across 2,377 interventional studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

Children's Mercy Hospital Kansas City is the lead sponsor of 209 studies on the registry; 22 are open to participants now.

Of its 18 completed or terminated interventional studies of FDA-regulated products, 14 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 12-18 years of age (inclusive)
  • diagnosed with JIA by a pediatric rheumatologist
  • able to speak and read English and/or Spanish
  • able to complete online measures
  • reporting pain in at least one joint over the past 6 months

Exclusion criteria

Exclusion Criteria:

  • have another chronic medical condition that adversely impacts pain and/or health-related quality of life (e.g., inflammatory bowel disease, fibromyalgia, cancer, genetic disorder, pervasive developmental disorder, diabetes)
  • have a significant cognitive impairment or illiteracy that would prevent understanding of the intervention and outcome measures
  • currently in psychotherapy
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
305 participants (actual)

Study arms

  • Experimental
    Web-based coping skills training

    Involves completion of a 12-week interactive, multi-component, multimedia online training that consists of instruction in specific self-management strategies, disease education, and social support.

    Behavioral: Web-based coping skills training

  • Active comparator
    Online disease education

    Involves viewing 12 educational websites about Juvenile Idiopathic Arthritis over the course of 12 weeks.

    Behavioral: Online disease education

Interventions

  • BehavioralWeb-based coping skills training

    This intervention comprises a 12-week interactive, multi-component, multimedia online training that consists of instruction in specific self-management strategies, disease education, and social support. The content is rooted in cognitive-behavioral principles of disease self-management. In addition to the web-based modules, the intervention consists of monthly telephone support for 3 months by a trained bilingual health coach (research nurse) to review material and help enhance motivation.

  • BehavioralOnline disease education

    The online disease education intervention provides access to an online resource center containing links to 12 educational websites about Juvenile Idiopathic Arthritis. Participants will be asked to review one educational website per week over the course of 12 weeks. Participants also will receive three monthly phone calls by a bilingual nurse "health coach" to discuss the participant's efforts at managing his/her disease.

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity

    Pain intensity was assessed by patient-self report using an electronic numeric rating scale ranging from 0-10, with 0 being the lowest value ("no pain") and 10 being the highest value ("very much pain").

    Time frame: Baseline, post-treatment, 6-month follow-up, 12-month follow-up

  2. Change in PedsQL Rheumatology Health-Related Quality of Life Total Score

    Health-related quality of life was measured by patient self-report using an electronic version of the PedsQL Rheumatology Module. Responses on this scale are transformed into a 0-100 scale, with 0 being the worst value for health-related quality of life and 100 being the best possible value for health-related quality of life.

    Time frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up

Secondary outcomes

  1. Change in Medical Issues, Exercise, Pain and Social Support Questionnaire (MEPS) Education Score

    Knowledge about Juvenile Idiopathic Arthritis was measured by patient self-report using an electronic version of the Medical Issues, Exercise, Pain and Social support (MEPS) Questionnaire. Responses on this scale are measured on a 0-10 numeric rating scale and averaged together to form a summary score, with 0 being the worst possible score and 10 being the best possible score.

    Time frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up

  2. Change in Disease Activity

    Disease activity was assessed by the treating physician based on a complete joint count (count of the number of joints that are swollen, painful, tender, or restriction in motion). The lowest (best) value is 0, and the highest (worst) possible value is 300.

    Time frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up

  3. Change in Children's Arthritis Self-Efficacy (CASE) Scores

    Confidence in managing arthritis was measured by patient self-report using an electronic version of the Children's Arthritis Self-Efficacy (CASE) scale. Responses on a 5-point scale ("not at all sure" to "very sure") are averaged together to form a total score, with 0 being the worst possible value and 5 being the best possible value.

    Time frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up

  4. Change in Approach Coping

    Scores on the Approach Coping sub-scale of the Pain Coping Questionnaire were used to measure approach coping, which is a type of coping considered to be adaptive and helpful for pain. Responses to items on this subscale are on a 5-point scale ("never use" to "very often use") and are averaged together for the subscale score, such that scores range from a worst possible value of 1 to a best possible value of 5.

    Time frame: Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up

07

Results

Posted Mar 9, 2017

Participant flow

Participant flow — Overall Study
MilestoneWeb-based Coping Skills TrainingOnline Disease Education Control
Started144145
Completed129136
Not completed159
Withdrew: Lost to follow-up22
Withdrew: Withdrawal by subject137

Outcome measures

PrimaryChange in Pain Intensity

Pain intensity was assessed by patient-self report using an electronic numeric rating scale ranging from 0-10, with 0 being the lowest value ("no pain") and 10 being the highest value ("very much pain").

Time frame:
Baseline, post-treatment, 6-month follow-up, 12-month follow-up
Reported as:
Mean · Units on a scale
Change in Pain Intensity
Units on a scaleWeb-based Coping Skills TrainingOnline Disease Education Control
Baseline3.56 ± 2.333.26 ± 2.38
Post-Treatment3.07 ± 2.472.90 ± 2.45
6-Month Follow-Up2.87 ± 2.452.96 ± 2.29
12-Month Follow-Up3.07 ± 2.492.71 ± 2.43
Statistical analysis
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = <.001 · Slope: -.04 · 95% CI -.06 to -.02The parameter represents the average monthly change on the outcome variable since group procedures were initiated.
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = .51 · Slope: -.014 · 95% CI -.055 to .027The estimated parameter value represents the difference in the monthly change (since baseline) in the outcome variable attributed to being in the treatment group (web-based coping skills training) versus the control group (online disease education).
PrimaryChange in PedsQL Rheumatology Health-Related Quality of Life Total Score

Health-related quality of life was measured by patient self-report using an electronic version of the PedsQL Rheumatology Module. Responses on this scale are transformed into a 0-100 scale, with 0 being the worst value for health-related quality of life and 100 being the best possible value for health-related quality of life.

Time frame:
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
Reported as:
Mean · units on a scale
Change in PedsQL Rheumatology Health-Related Quality of Life Total Score
units on a scaleWeb-based Coping Skills TrainingOnline Disease Education
Baseline72.56 ± 15.5272.44 ± 15.81
Post-Treatment75.68 ± 16.6877.78 ± 15.02
6-Month Follow-Up77.32 ± 15.6477.12 ± 14.41
12-Month Follow-Up78.26 ± 16.2378.04 ± 14.33
Statistical analysis
  • Web-based Coping Skills Training vs Online Disease Education · Multilevel growth model · p = <.001 · Slope: .37 · 95% CI .27 to .46The parameter represents the average monthly change on the outcome variable since before group procedures were started.
  • Web-based Coping Skills Training vs Online Disease Education · Multilevel growth model · p = .59 · Slope: .053 · 95% CI -.144 to .252The estimated parameter value represents the difference in the monthly change (since baseline) in the outcome variable attributed to being in the treatment group (web-based coping skills training) versus the control group (online disease education).
SecondaryChange in Medical Issues, Exercise, Pain and Social Support Questionnaire (MEPS) Education Score

Knowledge about Juvenile Idiopathic Arthritis was measured by patient self-report using an electronic version of the Medical Issues, Exercise, Pain and Social support (MEPS) Questionnaire. Responses on this scale are measured on a 0-10 numeric rating scale and averaged together to form a summary score, with 0 being the worst possible score and 10 being the best possible score.

Time frame:
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
Reported as:
Mean · units on a scale
Change in Medical Issues, Exercise, Pain and Social Support Questionnaire (MEPS) Education Score
units on a scaleWeb-based Coping Skills TrainingOnline Disease Education
Baseline4.78 ± 2.354.57 ± 2.20
Post-Treatment6.27 ± 2.356.54 ± 2.03
6-Month Follow-Up6.62 ± 2.476.44 ± 2.40
12-Month Follow-Up6.45 ± 2.626.65 ± 2.28
Statistical analysis
  • Web-based Coping Skills Training vs Online Disease Education · Multilevel growth model · p = <.001 · Slope: .12 · 95% CI .10 to .14The parameter represents the average monthly change on the outcome variable since before group procedures were started
  • Web-based Coping Skills Training vs Online Disease Education · Multilevel growth model · p = .63 · Slope: -.01 · 95% CI -.05 to .03The estimated parameter value represents the difference in the monthly change (since baseline) in the outcome variable attributed to being in the treatment group (web-based coping skills training) versus the control group (online disease education).
SecondaryChange in Disease Activity

Disease activity was assessed by the treating physician based on a complete joint count (count of the number of joints that are swollen, painful, tender, or restriction in motion). The lowest (best) value is 0, and the highest (worst) possible value is 300.

Time frame:
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
Reported as:
Mean · joints
Change in Disease Activity
jointsWeb-based Coping Skills TrainingOnline Disease Education Control
Baseline6.97 ± 12.846.63 ± 11.18
Post-Treatment5.61 ± 9.696.43 ± 10.09
6-Month Follow-Up5.45 ± 8.295.35 ± 8.14
12-Month Follow-Up4.53 ± 7.686.17 ± 9.90
Statistical analysis
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = .02 · Slope: -.10 · 95% CI -.18 to -.01The parameter represents the average monthly change on the outcome variable since before group procedures were started.
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = .91 · Slope: -.009 · 95% CI -.174 to .155The estimated parameter value represents the difference in the monthly change (since baseline) in the outcome variable attributed to being in the treatment group (web-based coping skills training) versus the control group (online disease education).
SecondaryChange in Children's Arthritis Self-Efficacy (CASE) Scores

Confidence in managing arthritis was measured by patient self-report using an electronic version of the Children's Arthritis Self-Efficacy (CASE) scale. Responses on a 5-point scale ("not at all sure" to "very sure") are averaged together to form a total score, with 0 being the worst possible value and 5 being the best possible value.

Time frame:
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
Reported as:
Mean · units on a scale
Change in Children's Arthritis Self-Efficacy (CASE) Scores
units on a scaleWeb-based Coping Skills TrainingOnline Disease Education Control
Baseline3.31 ± .963.32 ± 1.05
Post-Treatment3.80 ± .883.67 ± .99
6-Month Follow-Up3.81 ± .943.73 ± 1.0
12-Month Follow-Up3.75 ± .963.81 ± .98
Statistical analysis
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = <.001 · Slope: .0316 · 95% CI .02 to .04The parameter represents the average monthly change on the outcome variable since before group procedures were started
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = .67 · Slope: -.004 · 95% CI -.02 to .013The estimated parameter value represents the difference in the monthly change (since baseline) in the outcome variable attributed to being in the treatment group (web-based coping skills training) versus the control group (online disease education).
SecondaryChange in Approach Coping

Scores on the Approach Coping sub-scale of the Pain Coping Questionnaire were used to measure approach coping, which is a type of coping considered to be adaptive and helpful for pain. Responses to items on this subscale are on a 5-point scale ("never use" to "very often use") and are averaged together for the subscale score, such that scores range from a worst possible value of 1 to a best possible value of 5.

Time frame:
Pre-intervention, post-intervention, 6-month follow-up, 12-month follow-up
Reported as:
Mean · units on a scale
Change in Approach Coping
units on a scaleWeb-based Coping Skills TrainingOnline Disease Education Control
Baseline2.63 ± .752.57 ± .73
Post-Treatment2.84 ± .872.67 ± .88
6-Month Follow-Up2.76 ± .902.55 ± .87
12-Month Follow-Up2.71 ± 1.032.55 ± .88
Statistical analysis
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = .58 · Slope: -.002 · 95% CI -.01 to .01The parameter represents the average monthly change on the outcome variable since before group procedures were started.
  • Web-based Coping Skills Training vs Online Disease Education Control · Multilevel growth model · p = .49 · Slope: .005 · 95% CI -.009 to .018The estimated parameter value represents the difference in the monthly change (since baseline) in the outcome variable attributed to being in the treatment group (web-based coping skills training) versus the control group (online disease education).

Adverse events

Collected over Adverse events were monitored throughout participants' active participation in the trial, through 12 month follow-up.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Web-based Coping Skills Training—4/144 (2.8%)38/144 (26.4%)
Online Disease Education Control—5/145 (3.4%)34/145 (23.4%)
Most frequent serious events
Most frequent serious events
EventWeb-based Coping Skills TrainingOnline Disease Education Control
HospitalizationGastrointestinal disorders1/1443/145
Arthritis flareMusculoskeletal and connective tissue disorders1/1440/145
Hospitalized for management of Crohn's disease flareImmune system disorders1/1440/145
Hospitalized for suicidal thoughtsPsychiatric disorders1/1440/145
Hospitalized for macrophage activation syndromeInfections and infestations0/1441/145
Hospitalized for appendicitisInfections and infestations0/1441/145
Most frequent other events
Most frequent other events
EventWeb-based Coping Skills TrainingOnline Disease Education Control
Arthritis flareImmune system disorders13/1444/145
InfectionInfections and infestations7/14411/145
Abdominal painGastrointestinal disorders1/1447/145
Skin system findings (psoriasis, rash)Skin and subcutaneous tissue disorders5/1443/145
Blood disorder/problemsBlood and lymphatic system disorders3/1442/145
DepressionPsychiatric disorders3/1441/145
Injury (e.g., sprain, fracture)Injury, poisoning and procedural complications2/1443/145
Dizziness and/or fatigueNervous system disorders2/1442/145
Suicidal thoughtsPsychiatric disorders2/1441/145

Baseline characteristics

Age, Continuous
Age, Continuous(years)Web-based Coping Skills TrainingOnline Disease Education ControlNever RandomizedTotal
Mean14.65 ± 1.8514.55 ± 1.7615.06 ± 1.6914.59 ± 1.79
Sex: Female, Male
Sex: Female, Male(Participants)Web-based Coping Skills TrainingOnline Disease Education ControlNever RandomizedTotal
Female9811113222
Male4634383
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Web-based Coping Skills TrainingOnline Disease Education ControlNever RandomizedTotal
Hispanic or Latino2117139
Not Hispanic or Latino12312815266
Unknown or Not Reported0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Web-based Coping Skills TrainingOnline Disease Education ControlNever RandomizedTotal
American Indian or Alaska Native3003
Asian55010
Native Hawaiian or Other Pacific Islander0202
Black or African American75113
White12012313256
More than one race910221
Unknown or Not Reported0000
08

Study locations

10 sites
  • University of California San Francisco Benioff Children's Hospital
    San Francisco, California 94143, United States
  • Lurie Children's Hospital
    Chicago, Illinois 60614-3363, United States
  • Riley Hospital for Children
    Indianopolis, Indiana 46202, United States
  • Children's Mercy Hospitals and Clinics
    Kansas City, Missouri 64108, United States
  • Joseph M. Sanzari Children's Hospital
    Hackensack, New Jersey 07601, United States
  • Duke University Medical Center
    Durham, North Carolina 27705, United States
  • Nationwide Children's Hospital
    Columbus, Ohio 43205, United States
  • The Children's Hospital at Legacy Emmanuel Medical Center
    Portland, Oregon 97227, United States
  • Dell Children's Medical Center of Central Texas
    Austin, Texas 78723, United States
  • Seattle Children's Hospital
    Seattle, Washington 98133, United States
09

References and documents

Individual participant data

Plan to share: Yes — A deidentified dataset is available for secondary analyses per our Resource Sharing Plan.

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01541917
Lead sponsor
Children's Mercy Hospital Kansas City
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Responsible party
Sponsor
First posted
Mar 1, 2012
Start date
Jul 2012
Primary completion
Apr 2016
Completion
Jun 2016
Results posted
Mar 9, 2017
Last update
Mar 9, 2017

Study contacts

Mark A Connelly, PhD
principal investigator · Children's Mercy Hospital Kansas City
Jennifer Stinson, PhD
principal investigator · The Hospital for Sick Children

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion